Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

featured

Published in Gastroenterology

Journal Scan / Research · November 04, 2021

Vedolizumab and Anti-TNFα Outcomes in Biologic-Naïve Patients With IBD

Journal of Crohn's & Colitis

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Amar Naik MD

Journal of Crohn's & Colitis

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

J Crohns Colitis 2021 Oct 07;15(10)1694-1706, B Bressler, A Yarur, MS Silverberg, M Bassel, E Bellaguarda, C Fourment, A Gatopoulou, P Karatzas, U Kopylov, G Michalopoulos, S Michopoulos, U Navaneethan, DT Rubin, J Siffledeen, A Singh, K Soufleris, D Stein, D Demuth, GJ Mantzaris

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Vedolizumab and Anti-TNFα Outcomes in Biologic-Naïve Patients With IBD

Additional Info

Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study

Further Reading

Environmental Impact of Gastroenterology and Strategies for Sustainable Practices

Pancreas-Directed AAV8-hSPINK1 Gene Therapy in Mouse Models of Pancreatitis

Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis

Risk Factors and Treatment Strategies for Cholecystitis After Metallic Stent Placement for Malignant Biliary Obstruction

Low Rates of Metastases After Endoscopic Submucosal Dissection of Early Esophageal Adenocarcinoma With Poor Differentiation

Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease

Association Between Histologic Activity and the Risk of Serious Infections in Patients With IBD

Ultra-Processed Food Consumption and Long-Term IBS Risk

Real-World Surgical and Endoscopic Recurrence Outcomes Based on Risk Profiles and Prophylaxis Utilization in Patients With Postoperative Crohn's Disease

Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment

Next-Generation Multitarget Stool DNA Test for Colorectal Cancer Screening

Recently Updated